Clopidogrel resistance: poor metabolizers do not effectively convert it into active form because of low CYP2C19 activity causing a reduced effectiveness.
Familial hypercholesterolemia is an autosomal dominant disorder caused by mutations in the gene encoding the receptor for low density lipoprotein (LDL).
Newer antithrombotics in atrial fibrillation: DTI -dabigatran, direct factor Xa inhibitors - rivaroxaban, apixaban, edoxaban; vitamin K analogue tecarfarin.